Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011) [Phase 2]
Phase 2 clinical trial evaluating MK-1029 for persistent asthma not controlled with montelukast; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers [Phase 1]
Phase 1 trial evaluating subcutaneous delivery of tralokinumab at different flow rates in healthy volunteers.
-
FDA approval · 2018-11-19FDA Tentative Approval: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA issued tentative approval for Teva Respiratory's supplemental NDA for QVAR REDIHALER (beclomethasone dipropionate HFA). The inhaled cort…
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Best African American Response to Asthma Drugs [Phase 3]
Phase 3 clinical trial update on asthma treatments focusing on response in African American patients; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: The Houston HIITBAC for African Americans [NA]
Clinical trial update for the Houston HIITBAC study; completed with results posted in 2018, focusing on asthma in African American participa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-11-09FDA Approved: BUDESONIDE INHALATION — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals’ original application for budesonide inhalation, a generic inhaled corticosteroid for the maintenance tre…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects [Phase 1]
Phase 1 trial update evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of inhaled AZD8871 in asthmatic and COPD subjec…
-
FDA approval · 2018-11-07FDA Approved: PRIMATENE MIST — Original Application (Armstrong Pharmaceuticals, Inc.)
FDA approved Primatene Mist, an epinephrine inhalation product from Armstrong Pharmaceuticals, under an Original Application (NDA205920). Th…
-
FDA approval · 2018-11-05FDA Approved: LEVALBUTEROL INHALATION SOLUTION — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's levalbuterol inhalation solution as an original generic application. It is indicated for relief of broncho…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home [Phase 3]
Phase 3 trial evaluating home administration of a single-use auto-injector for benralizumab in asthma; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma [Phase 4]
Phase 4 trial update evaluating the effects of extra-fine versus coarse-particle inhaled corticosteroids on ventilation heterogeneity in chi…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma [Phase 3]
Phase 3 trial comparing FlutiForm pMDI 125/5 µg to Symbicort Turbohaler 200/6 µg in adolescents and adults with moderate to severe persisten…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma [Phase 3]
A Phase 3 trial comparing FlutiForm to Fluticasone Plus Formoterol in adults with severe asthma has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma [Phase 3]
Phase 3 randomized trial comparing Flutiform pMDI to Fluticasone/Formoterol DPI in adolescents and adults with persistent asthma; completed.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of Flutiform pMDI in adults with mild to moderate-severe reversible asthma is comple…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma [Phase 3]
Phase 3 trial comparing FLUTIFORM against Seretide in paediatric asthma completed.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients [Phase 3]
Phase 3 trial comparing Flutiform, Fluticasone, and Seretide in paediatric patients with moderate to severe asthma has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma [Phase 2]
Phase 2 trial assessing airway inflammation effects of FlutiForm pMDI at low and high doses in adults with mild to moderate asthma has compl…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) [Phase 3]
Phase 3 trial evaluating dupilumab in persistent asthma has completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma [Phase 3]
Phase 3 clinical trial update evaluating the effect of Fluticasone/Formoterol Breath Actuated Inhaler versus Relvar Ellipta DPI on ventilati…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma [Phase 3]
Phase 3 clinical trial evaluating dupilumab in severe steroid-dependent asthma has completed with posted results.
-
FDA approval · 2018-10-19FDA Approved: DUPIXENT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for DUPIXENT (dupilumab) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Effect of Vilanterol on Methacholine Challenge Results [Phase 4]
Phase 4 trial update evaluating the effect of vilanterol on methacholine challenge results in asthma patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Noninvasive Neurostimulation of the Vagus Nerve for the Relief of Acute Bronchoconstriction Due to Asthma [NA]
Clinical trial update for noninvasive vagus nerve stimulation aimed at relieving acute bronchoconstriction in asthma; study terminated with …
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children [Phase 4]
Phase 4 trial comparing a single dose of oral dexamethasone to multi-dose prednisolone for acute asthma exacerbations in children.